Home  »  Industry   »  The Stars are Aligning for Holders of Catalyst Pha...

The Stars are Aligning for Holders of Catalyst Pharmaceuticals Inc. (CPRX)

At the end of the latest market close, Catalyst Pharmaceuticals Inc. (CPRX) was valued at $12.80. In that particular session, Stock kicked-off at the price of $12.82 while reaching the peak value of $13.08 and lowest value recorded on the day was $12.40. The stock current value is $12.46.Recently in News on September 12, 2022, Catalyst Pharmaceuticals Set to Join S&P SmallCap 600. Catalyst Pharmaceuticals Inc. (NASD: CPRX) will replace Mantech International Corp. (NASD: MANT) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, September 15. The Carlyle Group Inc. (NASD: CG) is acquiring ManTech International in a transaction expected to be completed soon pending final conditions. You can read further details here

Catalyst Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $17.22 on 09/13/22, with the lowest value was $5.24 for the same time period, recorded on 01/28/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Catalyst Pharmaceuticals Inc. (CPRX) full year performance was 154.81%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Catalyst Pharmaceuticals Inc. shares are logging -27.64% during the 52-week period from high price, and 157.97% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.83 and $17.22.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2460434 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Catalyst Pharmaceuticals Inc. (CPRX) recorded performance in the market was 84.05%, having the revenues showcasing 89.65% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.30B, as it employees total of 76 workers.

Analysts verdict on Catalyst Pharmaceuticals Inc. (CPRX)

During the last month, 0 analysts gave the Catalyst Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 9.70, with a change in the price was noted +4.64. In a similar fashion, Catalyst Pharmaceuticals Inc. posted a movement of +59.34% for the period of last 100 days, recording 2,484,924 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CPRX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Catalyst Pharmaceuticals Inc. (CPRX): Technical Analysis

Raw Stochastic average of Catalyst Pharmaceuticals Inc. in the period of last 50 days is set at 50.97%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.24%. In the last 20 days, the company’s Stochastic %K was 5.85% and its Stochastic %D was recorded 9.55%.

Let’s take a glance in the erstwhile performances of Catalyst Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 84.05%. Additionally, trading for the stock in the period of the last six months notably improved by 50.30%, alongside a boost of 154.81% for the period of the last 12 months. The shares increased approximately by -19.72% in the 7-day charts and went down by -12.93% in the period of the last 30 days. Common stock shares were driven by 89.65% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts